Back to search

United States· US:55910-552_cd63fc06-3ea0-4e38-a744-976ada520fdd

Eye Allergy Relief

A medicinal product containing naphazoline hydrochloride; pheniramine maleate, registered in United States by DOLGENCORP, LLC.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedEye Allergy ReliefATC—REGISTER NO.US:55910-552_cd63fc06…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE
Manufacturer
DOLGENCORP, LLC
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    55910-552-15
  • ndc11
    5591055215
    1 BOTTLE, DROPPER in 1 CARTON (55910-552-15) / 15 mL in 1 BOTTLE, DROPPER

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Naphazoline hydrochloride; pheniramine maleate in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All naphazoline hydrochloride; pheniramine maleate products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Belgium · Naphcon-A

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f4e8c86c-5987-4d2e-85f6-8798342b04da
GET /v1/drugs/f4e8c86c-5987-4d2e-85f6-8798342b04da?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "OPHTHALMIC",
  "source": "ndc",
  "strength": ".2675; 3.15",
  "substance": "NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE",
  "productndc": "55910-552",
  "dosage_form": "SOLUTION/ DROPS",
  "dea_schedule": null,
  "strength_unit": "mg/mL; mg/mL",
  "application_number": "NDA020065",
  "marketing_category": "NDA"
}

See everything about naphazoline hydrochloride; pheniramine maleate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.